An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
|Articles|October 13, 2017
Survivor: A Poem
Author(s)Beverly L Crawford
Advertisement
Editor’s Note: This piece was submitted by a contributing writer and does not represent the views of CURE Media Group.
I'm a cancer survivor
I want you to know
I'm a cancer survivor
I live with a glow
I'm a cancer survivor
And happy to be
I'm a cancer survivor
And glad to be me
I see that you're a survivor too
We are so alike, just me and you
We savor our time be it joy or strife
​Each breath is a gift - a sweet breath of life
Advertisement
Related to this article
After 19 years of survivorship, one cancer survivor reflects on life's changing seasons, managing scan anxiety and finding support beyond treatment.
Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.
Among more than 12,000 cancer survivors 65 and older, those who stayed physically active after diagnosis tended to have lower health care costs, an American Cancer Society study published Oct. 21, 2026, in CANCER found.
The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Advertisement
Advertisement
Trending on CURE
1
What Liquid Biopsy and ESR1 Mutations Mean in Breast Cancer
2
FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors
3
Gemcitabine Plus BCG Clears Bladder Cancer in 96% of Patients After BCG Failure
4
Finding My Rhythm Again: What Fall Means to Me After Cancer
5